{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:37:49Z","timestamp":1789763869724,"version":"4.0.1"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Clinical hypothyroidism is defined by the inadequate production of thyroid hormone from the thyroid gland to maintain normal organ system functions. For nearly all patients with clinical hypothyroidism, lifelong treatment with thyroid hormone replacement is required. The primary goal of treatment is to provide the appropriate daily dose of thyroid hormone to restore normal thyroid function for each individual patient. In current clinical practice, normalization of thyrotropin (TSH) level is the primary measure of effectiveness of treatment, however the use of a single biomarker to define adequate thyroid hormone replacement is being reevaluated. The assessment of clinical health outcomes and patient-reported outcomes (PROs), often within the context of intensity of treatment as defined by thyroid function tests (i.e., undertreatment, appropriate treatment, or overtreatment), may play a role in evaluating the effectiveness of treatment. The purpose of this narrative review is to summarize the prominent health outcomes literature in patients with treated hypothyroidism. To date, overall mortality, cardiovascular morbidity and mortality, bone health and cognitive function have been evaluated as endpoints in clinical outcomes studies in patients with treated hypothyroidism. More recent investigations have sought to establish the relationships between these end results and thyroid function during the treatment course. In addition to clinical event outcomes, patient-reported quality of life (QoL) has also been considered in the assessment of adequacy of hypothyroidism treatment. From a health care quality perspective, treatment of hypothyroidism should be evaluated not just on its effectiveness for the individual patients but also to the extent to which patients of different sociodemographic groups are treated equally. Ultimately, more research is needed to explore differences in health outcomes between different sociodemographic groups with hypothyroidism. Future prospective studies of treated hypothyroidism that integrate biochemical testing, PROs, and end result clinical outcomes could provide a more complete picture into the effectiveness of treatment of hypothyroidism.<\/jats:p>","DOI":"10.3389\/fendo.2022.1026262","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T06:36:01Z","timestamp":1666074961000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluating health outcomes in the treatment of hypothyroidism"],"prefix":"10.3389","volume":"13","author":[{"given":"Matthew D.","family":"Ettleson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papaleontiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"B1","unstructured":"Types of health care quality measuresRockville, Maryland, USAAgency for Healthcare Research and QualityAgency of healthcare research and quality"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01361","article-title":"Systemic thyroid hormone status during levothyroxine therapy in hypothyroidism: A systematic review and meta-analysis","volume":"103","author":"McAninch","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0681","article-title":"An online survey of hypothyroid patients demonstrates prominent dissatisfaction","volume":"28","author":"Peterson","year":"2018","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.2686","article-title":"Levothyroxine use in the united states, 2008-2018","volume":"181","author":"Brito","year":"2021","journal-title":"JAMA Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02006-8","article-title":"Thyroxine and treatment of hypothyroidism: seven decades of experience","volume":"66","author":"Mateo","year":"2019","journal-title":"Endocrine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7326\/M15-1799","article-title":"The history and future of treatment of hypothyroidism","volume":"164","author":"McAninch","year":"2016","journal-title":"Ann Internal Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.243.6.549","article-title":"Hormonal content of thyroid replacement preparations","volume":"243","author":"Reesjones","year":"1980","journal-title":"Jama-J Am Med Assoc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105234","article-title":"Radioimmunoassay of human plasma thyrotropin","volume":"44","author":"Utiger","year":"1965","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106304","article-title":"Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects","volume":"49","author":"Braverman","year":"1970","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.0045","article-title":"Association between generic-to-Generic levothyroxine switching and thyrotropin levels among US adults","volume":"182","author":"Brito","year":"2022","journal-title":"JAMA Internal Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa430","article-title":"Individualized therapy for hypothyroidism: Is T4 enough for everyone","volume":"105","author":"Ettleson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14340","article-title":"Patient satisfaction and quality of life in hypothyroidism: An online survey by the british thyroid foundation","volume":"94","author":"Mitchell","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0365-4","article-title":"Time for a reassessment of the treatment of hypothyroidism","volume":"19","author":"Midgley","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jcem-49-1-1","article-title":"Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypo-thyroidism and lowering blood lipid-levels in hypothyroid patients","volume":"49","author":"Gorman","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0345","article-title":"Effects of levothyroxine replacement or suppressive therapy on energy expenditure and body composition","volume":"26","author":"Samuels","year":"2016","journal-title":"Thyroid"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa097","article-title":"Resting energy expenditure in obese women with primary hypothyroidism and appropriate levothyroxine replacement therapy","volume":"105","author":"Muraca","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2660","article-title":"Is a normal TSH synonymous with \"Euthyroidism\" in levothyroxine monotherapy","volume":"101","author":"Peterson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081106","article-title":"Association between thyroid-stimulating hormone level after total thyroidectomy and hypercholesterolemia in female patients with differentiated thyroid cancer: A retrospective study","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000089","article-title":"Psychiatric and cognitive manifestations of hypothyroidism","volume":"21","author":"Samuels","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156925","article-title":"Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy","volume":"11","author":"Winther","year":"2016","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1649-6","article-title":"Cognitive functioning and quality of life in patients with hashimoto thyroiditis on long-term levothyroxine replacement","volume":"62","author":"Djurovic","year":"2018","journal-title":"Endocrine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clinthera.2017.01.005","article-title":"Factors affecting gastrointestinal absorption of levothyroxine: A review","volume":"39","author":"Skelin","year":"2017","journal-title":"Clin Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0218-2","article-title":"Deiodinases and their intricate role in thyroid hormone homeostasis","volume":"15","author":"Luongo","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocr Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1833","article-title":"Mortality and vascular outcomes in patients treated for thyroid dysfunction","volume":"91","author":"Flynn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.150.10.2077","article-title":": Morbidity, mortality, and quality-of-life for patients treated with levothyroxine","volume":"150","author":"Petersen","year":"1990","journal-title":"Arch Internal Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.680647","article-title":"Risk of all-cause mortality in levothyroxine-treated hypothyroid patients: A nationwide Korean cohort study","volume":"12","author":"Sohn","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1453-8","article-title":"Pre-admission TSH levels predict long-term mortality in adults treated for hypothyroidism","volume":"58","author":"Akirov","year":"2017","journal-title":"Endocrine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1530\/EJE-16-0708","article-title":"Elevated TSH in adults treated for hypothyroidism is associated with increased mortality","volume":"176","author":"Akirov","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2215\/CJN.06920712","article-title":"Hypothyroidism and mortality among dialysis patients","volume":"8","author":"Rhee","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4892","article-title":"Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study","volume":"366","author":"Thayakaran","year":"2019","journal-title":"BMJ"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1229","article-title":"Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death","volume":"184","author":"Perros","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0517","article-title":"Over- and under-treatment of hypothyroidism is associated with excess mortality: A register-based cohort study","volume":"28","author":"Lillevang-Johansen","year":"2018","journal-title":"Thyroid"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-4910-7","article-title":"Frequency of thyroid function tests and examinations in participants of a population-based study","volume":"20","author":"Kiel","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0006","article-title":"Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk","volume":"180","author":"Lillevang-Johansen","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11863","article-title":"Association of thyroid hormone treatment intensity with cardiovascular mortality among US veterans","volume":"5","author":"Evron","year":"2022","journal-title":"JAMA Network Open"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01480.x","article-title":"Morbidity in patients on l-thyroxine - a comparison of those with a normal TSH to those with a suppressed TSH","volume":"37","author":"Leese","year":"1992","journal-title":"Clin Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-18-0551","article-title":"Increased cardiovascular risk in thyroid cancer patients taking levothyroxine: a nationwide cohort study in Korea","volume":"180","author":"Suh","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab444","article-title":"Thyroid hormone therapy and incident stroke","volume":"106","author":"Papaleontiou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","article-title":"Thyroid diseases and bone health","volume":"41","author":"Williams","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0234","article-title":"Risk of osteoporosis and fractures in patients with thyroid cancer: A case-control study in US veterans","volume":"24","author":"Papaleontiou","year":"2019","journal-title":"Oncologist"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4158\/1934-2403-26.3.359","article-title":"Fragility fractures in Male veterans on thyroid hormone therapy","volume":"26","author":"Papaleontiou","year":"2020","journal-title":"Endocr Pract"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2238","article-title":"Levothyroxine dose and risk of fractures in older adults: nested case-control study","volume":"342","author":"Turner","year":"2011","journal-title":"Bmj-British Med J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/jbmr.2416","article-title":"The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: An observational register-based time-resolved cohort analysis","volume":"30","author":"Abrahamsen","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1992.tb02130.x","article-title":"Cognitive function in non-demented older adults with hypothyroidism","volume":"40","author":"Osterweil","year":"1992","journal-title":"J Am Geriatr Soc"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2702","article-title":"Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism","volume":"94","author":"Correia","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2007.19.2.132","article-title":"Verbal memory retrieval deficits associated with untreated hypothyroidism","volume":"19","author":"Miller","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1089\/10507250152741037","article-title":"Hypothyroidism and cognition: preliminary evidence for a specific defect in memory","volume":"11","author":"Burmeister","year":"2001","journal-title":"Thyroid"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2015.03.016","article-title":"Thyroid hormone: Influences on mood and cognition in adults","volume":"81","author":"Ritchie","year":"2015","journal-title":"Maturitas"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02025","article-title":"Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism","volume":"153","author":"Wekking","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.0252","article-title":"Health status, psychological symptoms, mood, and cognition in l-thyroxine-treated hypothyroid subjects","volume":"17","author":"Samuels","year":"2007","journal-title":"Thyroid"},{"key":"B55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2017.10.004","article-title":"Treated hypothyroidism is associated with cerebrovascular disease but not alzheimer's disease pathology in older adults","volume":"62","author":"Brenowitz","year":"2018","journal-title":"Neurobiol Aging"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2014.01.015","article-title":"Structural and functional MRI study of the brain, cognition and mood in long-term adequately treated hashimoto's thyroiditis","volume":"42","author":"Quinque","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2235","article-title":"Brain glucose metabolism in hypothyroidism: A positron emission tomography study before and after thyroid hormone replacement therapy","volume":"94","author":"Bauer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.8.3864","article-title":"Cerebral blood flow and glucose metabolism in hypothyroidism: A positron emission tomography study","volume":"86","author":"Constant","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0046","article-title":"Functional magnetic resource imaging assessment of altered brain function in hypothyroidism during working memory processing","volume":"164","author":"He","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0606","article-title":"Treated hypothyroidism, cognitive function, and depressed mood in old age: the rancho Bernardo study","volume":"161","author":"Kramer","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/00207450600550154","article-title":"Memory improvement with treatment of hypothyroidism","volume":"116","author":"Miller","year":"2006","journal-title":"Int J Neurosci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/s0248-8663(00)80022-3","article-title":"[Is cognitive change related to hypothyroidism reversible with replacement therapy","volume":"21","author":"Capet","year":"2000","journal-title":"Rev Med Interne"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0141","article-title":"Effect of thyroid function variations within the laboratory reference range on health status, mood, and cognition in levothyroxine-treated subjects","volume":"26","author":"Samuels","year":"2016","journal-title":"Thyroid"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1210\/jc.2017-02668","article-title":"Effects of altering levothyroxine (L-T4) doses on quality of life, mood, and cognition in l-T4 treated subjects","volume":"103","author":"Samuels","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.12.003","article-title":"Brain fog in hypothyroidism: Understanding the patient's perspective","volume":"28","author":"Ettleson","year":"2022","journal-title":"Endocr Pract"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/thy.2010.0092","article-title":"An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits","volume":"21","author":"Boucai","year":"2011","journal-title":"Thyroid"},{"key":"B67","volume-title":"Patient-Reported Outcome Measures","year":"2022"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9460-8","article-title":"Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination","volume":"18","author":"Watt","year":"2009","journal-title":"Qual Life Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0521","article-title":"Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO","volume":"162","author":"Watt","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jclinepi.2016.03.006","article-title":"A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases","volume":"78","author":"Wong","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0209","article-title":"Development of a short version of the thyroid-related patient-reported outcome ThyPRO","volume":"25","author":"Watt","year":"2015","journal-title":"Thyroid"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1709989","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"377","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0026","article-title":"Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO","volume":"10","author":"Nordqvist","year":"2021","journal-title":"Endocr Connect"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2004.14.916","article-title":"Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism","volume":"14","author":"McMillan","year":"2004","journal-title":"Thyroid"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071386","article-title":"What is the quality of life in patients treated with levothyroxine for hypothyroidism and how are we measuring it? a critical, narrative review","volume":"10","author":"Borson-Chazot","year":"2021","journal-title":"J Clin Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1869","article-title":"The beneficial effect of l-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: Randomized, crossover trial","volume":"92","author":"Razvi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00232.x","article-title":"Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQoL and ThySRQ","volume":"11","author":"McMillan","year":"2008","journal-title":"Value Health"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-68","article-title":"Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ","volume":"11","author":"Quinque","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1159\/000490383","article-title":"Levothyroxine\/Liothyronine combination therapy and quality of life: Is it all about weight loss","volume":"7","author":"Michaelsson","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02449-4","article-title":"Correlation between TSH levels and quality of life among subjects with well-controlled primary hypothyroidism","volume":"72","author":"Moron-Diaz","year":"2021","journal-title":"Endocrine"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3686","article-title":"The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition","volume":"99","author":"Samuels","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100101","article-title":"Persisting symptoms in patients with hashimoto's disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? a systematic review","volume":"4","author":"Groenewegen","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/B:QURE.0000015315.35184.66","article-title":"Health-related quality of life in patients with thyroid disorders - a study based on short-form 36 and Nottingham health profile questionnaires","volume":"13","author":"Bianchi","year":"2004","journal-title":"Qual Life Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24886","article-title":"Quality of life after thyroidectomy in patients with nontoxic nodular goiter: A prospective cohort study","volume":"39","author":"Sorensen","year":"2017","journal-title":"Head Neck-J For Sci Spec Head Neck"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"B86","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/cen.12824","article-title":"Management of primary hypothyroidism: statement by the British thyroid association executive committee","volume":"84","author":"Okosieme","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0099","article-title":"Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: Results of a double-blind, randomized clinical trial","volume":"91","author":"Walsh","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: A review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0720","article-title":"Evidence-based use of Levothyroxine\/Liothyronine combinations in treating hypothyroidism: A consensus document","volume":"31","author":"Jonklaas","year":"2021","journal-title":"Thyroid"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.11.017","article-title":"Disparities in thyroid care","volume":"51","author":"Chen","year":"2022","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2020.02.190159","article-title":"Thyroid hormone use in the united states, 1997-2016","volume":"33","author":"Johansen","year":"2020","journal-title":"J Am Board Fam Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-132","article-title":"Trends in thyroid hormone prescribing and consumption in the UK","volume":"9","author":"Mitchell","year":"2009","journal-title":"BMC Public Health"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab041","article-title":"Sociodemographic disparities in the treatment of hypothyroidism: NHANES 2007-2012","volume":"5","author":"Ettleson","year":"2021","journal-title":"J Endocr Soc"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1530\/eje-13-0459","article-title":"Changes in the prevalence of hypothyroidism: the HUNT study in Norway","volume":"169","author":"Asvold","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1089\/ct.2020;32.529-533","article-title":"Racial disparities in thyroid disease care","volume":"32","author":"Gavigan","year":"2020","journal-title":"Clin Thyroidology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glr063","article-title":"Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study","volume":"66","author":"Somwaru","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0485","article-title":"Risk of over- and under- treatment with levothyroxine in primary care in Copenhagen, Denmark","volume":"185","author":"la Cour","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1089\/heq.2018.0051","article-title":"Disparities in thyroid screening and medication use in Quebec, Canada","volume":"3","author":"Stoll","year":"2019","journal-title":"Health Equity"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00057","article-title":"Variation in treatment practices for subclinical hypothyroidism in pregnancy: US national assessment","volume":"104","author":"Maraka","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B100","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1210\/jc.2009-1845","article-title":"Age- and race-based serum thyrotropin reference limits","volume":"95","author":"Surks","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.060199","article-title":"Disparities in cardiovascular mortality between black and white adults in the united states, 1999 to 2019","volume":"146","author":"Kyalwazi","year":"2022","journal-title":"Circulation"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes challenges and interventions","volume":"137","author":"Schultz","year":"2018","journal-title":"Circulation"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4417","article-title":"Racial and ethnic disparities in bone health and outcomes in the united states","volume":"36","author":"Noel","year":"2021","journal-title":"J Bone Miner Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1026262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T06:36:10Z","timestamp":1666074970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1026262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":103,"alternative-id":["10.3389\/fendo.2022.1026262"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1026262","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"article-number":"1026262"}}